The Case against a Smoker's License
:
Background to the debate
Tobacco continues to kill millions of people around the world each year and its use is increasing in some countries, which makes the need for new, creative, and radical efforts to achieve the tobacco control endgame vitally important. One such effort is discussed in this PLOS Medicine Debate, where Simon Chapman presents his proposal for a “smoker's license” and Jeff Collin argues against. Chapman sets out a case for introducing a smart card license for smokers designed to limit access to tobacco products and encourage cessation. Key elements of the smoker's license include smokers setting daily limits, financial incentives for permanent license surrender, and a test of health risk knowledge for commencing smokers. Collin argues against the proposal, saying that it would shift focus away from the real vector of the epidemic—the tobacco industry—and that by focusing on individuals it would censure victims, increase stigmatization of smokers, and marginalize the poor.
Vyšlo v časopise:
The Case against a Smoker's License. PLoS Med 9(11): e32767. doi:10.1371/journal.pmed.1001343
Kategorie:
The Debate
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001343
Souhrn
:
Background to the debate
Tobacco continues to kill millions of people around the world each year and its use is increasing in some countries, which makes the need for new, creative, and radical efforts to achieve the tobacco control endgame vitally important. One such effort is discussed in this PLOS Medicine Debate, where Simon Chapman presents his proposal for a “smoker's license” and Jeff Collin argues against. Chapman sets out a case for introducing a smart card license for smokers designed to limit access to tobacco products and encourage cessation. Key elements of the smoker's license include smokers setting daily limits, financial incentives for permanent license surrender, and a test of health risk knowledge for commencing smokers. Collin argues against the proposal, saying that it would shift focus away from the real vector of the epidemic—the tobacco industry—and that by focusing on individuals it would censure victims, increase stigmatization of smokers, and marginalize the poor.
Zdroje
1. CallardC, CollishawNE (2012) Exploring vector space: overcoming resistance to direct control of the tobacco industry. Tob Control 21: 291–292.
2. BorlandR (2012) The need for new strategies to combat the epidemic of smoking-related harm. Tob Control 21: 287–288.
3. ThomsonG, EdwardsR, WilsonN, BlakelyT (2012) What are the elements of the tobacco endgame? Tob Control 21: 293–295.
4. ChapmanS (2012) The case for a smoker's license. PLoS Med 9: e 1001342 doi 10.1371/journal.pmed.1001342
5. McNeillA, LewisS, QuinnC, MulchyM, ClancyL, et al. (2010) Evaluation of the removal of point-of-sale tobacco displays in Ireland. Tob Control 20: 137–143.
6. ScheffelsJ, LavikR (2012) Out of sight, out of mind? Removal of point-of-sale tobacco displays in Norway. Tob Control In press.
7. PopovaS, GiesbrechtN, BekmuradovD, PatraJ (2009) Hours and days of sale and density of alcohol outlets: impacts on alcohol consumption and damage. a systematic review. Alcohol Alcohol 44: 500–516.
8. Alexia CampbellC, HahnRA, ElderR, BrewerR, ChattopadhyayS, et al. (2009) The effectiveness of limiting alcohol outlet density as a means of reducing excessive alcohol consumption and alcohol-related harms. Am J Prev Med 37: 556–569.
9. JahielRI, BaborTF (2007) Industrial epidemics, public health advocacy and the alcohol industry: lessons from other fields. Addiction 102: 1335–1339.
10. GilmoreAB, SavellE, CollinJ (2011) Public health, corporations and the new responsibility deal: promoting partnerships with vectors of disease? J Public Health 33: 2–4.
11. CollinJ (2012) Tobacco control, global health policy and development: towards policy coherence in global governance. Tob Control 21: 274–280.
12. World Health Organization (2012) Confronting the tobacco epidemic in a new era of trade and investment liberalization. Available: http://whqlibdoc.who.int/publications/2012/9789241503723_eng.pdf. Accessed 14 September 2012. Geneva: WHO.
13. HastingsG (2102) Why corporate power is a public health priority. BMJ 345: e5124.
14. CallardC, ThompsonD, CollishawN (2005) Transforming the tobacco market: why the supply of cigarettes should be transferred from for-profit corporations to non-profit enterprises with a public health mandate. Tob Control 14: 278–283.
15. Mill JS (1859) On liberty. Gray J, editor. On liberty and other essays. New York: Oxford University Press.
16. SchneiderN, GlantzSA (2008) “Nicotine Nazis strike again”: a brief analysis of the use of Nazi rhetoric in attacking tobacco control advocacy. Tob Control 17: 291–296.
17. BayerR (2008) Stigma and the ethics of public health: not can we but should we. Soc Sci Med 67: 463–472.
18. RitchieD, AmosA, MartinC (2010) “But it just has that sort of feel about it, a leper” – stigma, smoke-free legislation and public health. Nicotine Tob Res 12: 622–629.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2012 Číslo 11
- Statinová intolerance
- Hydroresponzivní krytí v epitelizační fázi hojení rány
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based Map
- Screening for Chronic Kidney Disease: Preventing Harm or Harming the Healthy?
- The Long-Term Health Consequences of Child Physical Abuse, Emotional Abuse, and Neglect: A Systematic Review and Meta-Analysis
- Screening and Rapid Molecular Diagnosis of Tuberculosis in Prisons in Russia and Eastern Europe: A Cost-Effectiveness Analysis